Citation tools
"A Prospective, Randomized, Double-Blind Study to Evaluate the Safety, Biodistribution, and Dosimetry of 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 in Patients with Well-Differentiated Neuroendocrine Tumors." Journal of Nuclear Medicine
62.10
(2021):
1398-1405.
Web. 19 April. 2024.